Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine–Nanobody Complex

por Desmyter, Aline, Spinelli, Silvia, Boutton, Carlo, Saunders, Michael, Blachetot, Christophe, de Haard, Hans, Denecker, Geertrui, Van Roy, Maarten, Cambillau, Christian, Rommelaere, Heidi
Publicado 2017

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

por Van Roy, Maarten, Ververken, Cedric, Beirnaert, Els, Hoefman, Sven, Kolkman, Joost, Vierboom, Michel, Breedveld, Elia, ‘t Hart, Bert, Poelmans, Sofie, Bontinck, Lieselot, Hemeryck, Alex, Jacobs, Sandy, Baumeister, Judith, Ulrichts, Hans
Publicado 2015